Search results
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX)
ETF DAILY NEWS· 19 hours agoForte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) saw some unusual options trading on Wednesday. Investors purchased 30,205 call options on the company. This is an & ...
Aptose Biosciences (APTO) Upgraded to Buy: What Does It Mean for the Stock?
Zacks via Yahoo Finance· 10 hours agoAptose Biosciences (APTO) might move higher on growing optimism about its earnings prospects, which...
Is Castle Biosciences (CSTL) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 12 hours agoThis means that Castle Biosciences, Inc. is performing better than its sector in terms of...
Bioscience jobs growth recently stalled in CT. But industry supporters are still optimistic.
Stamford Advocate· 2 days agoJobs growth in Connecticut's bioscience industry stalled last year, according to new state data —...
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
ETF DAILY NEWS· 1 day agoAkoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) has earned an average rating of “Moderate Buy” from the eight analysts that are currently covering the company, Marketbeat ...
Selling Buzz: Twist Bioscience Corp [TWST] Chief Executive Officer Leproust Emily M. sells 4,163...
Knox Daily· 7 days agoSupport And Resistance Levels for Twist Bioscience Corp (TWST) According to the 24-hour chart, there is a support level at 50.81, which, if violated, would...Moving Average ...
Retail investors invested in Kuros Biosciences AG (VTX:KURN) up 13% last week, insiders too were...
Simply Wall St. via Yahoo Finance· 4 days agoFollowing a 13% increase in the stock price last week, retail investors profited the most, but...
Skye Bioscience to stop eye disease drug development after failing mid-stage study
WSAU Wausau· 4 days ago(Reuters) -Skye Bioscience said on Monday it would discontinue development of its experimental eye disease treatment after the drug failed to meet the main goal of a mid-stage ...
Twist Bioscience (NASDAQ:TWST) Trading Down 4.2% Following Insider Selling
ETF DAILY NEWS· 2 days agoTwist Bioscience Co. (NASDAQ:TWST – Get Free Report)’s stock price traded down 4.2% on Monday following insider selling activity. The company traded as low as $48.17 and last ...
Clare Kahn, director at Solid Biosciences, buys $8.4k in stock By Investing.com
Investing.com· 2 days agoClare Kahn, a director of Solid Biosciences Inc. (NASDAQ:SLDB), a company specializing in biological...